Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ptc Therapeutics (PTCT) Consolidated Net Income: 2012-2025

Historic Consolidated Net Income for Ptc Therapeutics (PTCT) over the last 14 years, with Sep 2025 value amounting to $15.9 million.

  • Ptc Therapeutics' Consolidated Net Income rose 114.90% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $489.4 million, marking a year-over-year increase of 190.32%. This contributed to the annual value of -$625.6 million for FY2024, which is 12.53% up from last year.
  • According to the latest figures from Q3 2025, Ptc Therapeutics' Consolidated Net Income is $15.9 million, which was up 124.51% from -$64.8 million recorded in Q2 2025.
  • In the past 5 years, Ptc Therapeutics' Consolidated Net Income ranged from a high of $866.6 million in Q1 2025 and a low of -$328.2 million during Q4 2024.
  • In the last 3 years, Ptc Therapeutics' Consolidated Net Income had a median value of -$106.7 million in 2024 and averaged -$47.6 million.
  • In the last 5 years, Ptc Therapeutics' Consolidated Net Income tumbled by 91.74% in 2021 and then surged by 1,046.28% in 2025.
  • Ptc Therapeutics' Consolidated Net Income (Quarterly) stood at -$143.3 million in 2021, then decreased by 21.82% to -$174.5 million in 2022, then plummeted by 40.05% to -$244.4 million in 2023, then crashed by 34.27% to -$328.2 million in 2024, then soared by 114.90% to $15.9 million in 2025.
  • Its Consolidated Net Income was $15.9 million in Q3 2025, compared to -$64.8 million in Q2 2025 and $866.6 million in Q1 2025.